Bharat Immunological & Biologicals Corporation Share Price
₹24.40 +0.3 (1.24%)
03 Jan, 2025 09:23
Start SIP in BIBCL
Start SIPPerformance
- Low
- ₹0
- High
- ₹0
- 52 Week Low
- ₹0
- 52 Week High
- ₹0
- Open Price₹0
- Previous Close₹0
- Volume0
Investment Returns
- Over 1 Month + 2.22%
- Over 3 Month -14.18%
- Over 6 Month -14.45%
- Over 1 Year -29.05%
Smart Investing Starts Here Start SIP with Bharat Immunological & Biologicals Corporation for Steady Growth!
Bharat Immunological & Biologicals Corporation Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
Bharat Immunological & Biologicals Corporation Financials
Bharat Immunological & Biologicals Corporation Technicals
EMA & SMA
Current Price
₹24.40
+
0.3
(1.24%)
- Bullish Moving Average 6
- Bearish Moving Average 10
- 20 Day
- ₹24.30
- 50 Day
- ₹24.96
- 100 Day
- ₹26.14
- 200 Day
- ₹27.33
Resistance and Support
24.09
- R3 25.04
- R2 24.72
- R1 24.41
- S1 23.78
- S2 23.46
- S3 23.15
Bharat Immunological & Biologicals Corporation Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2024-08-16 | General Purpose. | |
2024-03-08 | Others | General Purpose |
2023-10-31 | Quarterly Results | |
2023-04-24 | Audited Results | |
2023-02-09 | Quarterly Results |
Bharat Immunological & Biologicals Corporation F&O
About Bharat Immunological & Biologicals Corporation
- NSE Symbol
- BIBCL
- BSE Symbol
- 524663
- ISIN
- INE994B01014
Similar Stocks to Bharat Immunological & Biologicals Corporation
Bharat Immunological & Biologicals Corporation FAQs
Bharat Immunological & Biologicals Corporation share price is ₹24 As on 03 January, 2025 | 09:09
The Market Cap of Bharat Immunological & Biologicals Corporation is ₹105.4 Cr As on 03 January, 2025 | 09:09
The P/E ratio of Bharat Immunological & Biologicals Corporation is -5.7 As on 03 January, 2025 | 09:09
The PB ratio of Bharat Immunological & Biologicals Corporation is 1.2 As on 03 January, 2025 | 09:09
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.